Brown Capital Management LLC Glaukos Corp Transaction History

Brown Capital Management LLC

$3.34 Billion
Q2 2025

A detailed history of Brown Capital Management LLC transactions in Glaukos Corp stock. As of the latest transaction made, Brown Capital Management LLC holds 1,139,119 shares of GKOS stock, worth $102 Million. This represents 3.53% of its overall portfolio holdings.

Number of Shares

1,139,119

Previous 1,192,589 4.48%

Holding current value

$102 Million

Previous $117 Million 0.24%

% of portfolio

3.53%

Previous 3.63%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$82.27 - $103.29 $4.4 Million - $5.52 Million	-53,470 Reduced 4.48%	1,139,119 $118 Million
Q1 2025 May 15, 2025	SELL	$96.6 - $161.22 $15 Million - $25 Million	-155,268 Reduced 11.52%	1,192,589 $117 Million
Q4 2024 Feb 14, 2025	SELL	$126.42 - $152.67 $36.2 Million - $43.8 Million	-286,734 Reduced 17.54%	1,347,857 $202 Million
Q3 2024 Nov 12, 2024	SELL	$113.62 - $135.39 $29.9 Million - $35.7 Million	-263,365 Reduced 13.88%	1,634,591 $213 Million
Q2 2024 Aug 12, 2024	SELL	$89.48 - $118.35 $21 Million - $27.8 Million	-234,891 Reduced 11.01%	1,897,956 $225 Million
Q1 2024 May 15, 2024	SELL	$76.4 - $96.33 $43.2 Million - $54.4 Million	-564,947 Reduced 20.94%	2,132,847 $201 Million
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $5.32 Million - $7.61 Million	89,420 Added 3.43%	2,697,794 $214 Million
Q3 2023 Nov 14, 2023	SELL	$69.23 - $79.09 $1.99 Million - $2.27 Million	-28,720 Reduced 1.09%	2,608,374 $196 Million
Q2 2023 Aug 14, 2023	SELL	$45.44 - $71.21 $12.2 Million - $19.1 Million	-267,564 Reduced 9.21%	2,637,094 $188 Million
Q1 2023 May 15, 2023	BUY	$43.88 - $52.48 $8.42 Million - $10.1 Million	191,849 Added 7.07%	2,904,658 $146 Million
Q4 2022 Feb 14, 2023	SELL	$40.82 - $57.75 $5.99 Million - $8.48 Million	-146,845 Reduced 5.14%	2,712,809 $118 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $9.82 Million - $12.3 Million	209,589 Added 7.91%	2,859,654 $152 Million
Q2 2022 Aug 15, 2022	SELL	$34.86 - $63.77 $7.65 Million - $14 Million	-219,351 Reduced 7.64%	2,650,065 $120 Million
Q1 2022 May 16, 2022	SELL	$44.33 - $57.82 $6.76 Million - $8.81 Million	-152,380 Reduced 5.04%	2,869,416 $166 Million
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $7.81 Million - $11.1 Million	-194,062 Reduced 6.03%	3,021,796 $134 Million
Q3 2021 Nov 15, 2021	SELL	$47.43 - $84.23 $124 Million - $220 Million	-2,611,212 Reduced 44.81%	3,215,858 $155 Million
Q2 2021 Aug 16, 2021	SELL	$73.06 - $97.7 $38.6 Million - $51.6 Million	-527,779 Reduced 8.31%	5,827,070 $494 Million
Q1 2021 May 14, 2021	SELL	$70.43 - $97.42 $10.9 Million - $15 Million	-154,425 Reduced 2.37%	6,354,849 $533 Million
Q4 2020 Feb 16, 2021	SELL	$48.9 - $75.26 $3.01 Million - $4.63 Million	-61,487 Reduced 0.94%	6,509,274 $490 Million
Q3 2020 Nov 13, 2020	BUY	$37.23 - $50.97 $70.3 Million - $96.2 Million	1,888,286 Added 40.33%	6,570,761 $325 Million
Q2 2020 Aug 07, 2020	BUY	$28.78 - $46.83 $2.23 Million - $3.63 Million	77,524 Added 1.68%	4,682,475 $180 Million
Q1 2020 May 08, 2020	BUY	$25.53 - $70.14 $995,287 - $2.73 Million	38,985 Added 0.85%	4,604,951 $142 Million
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $39,117 - $47,392	722 Added 0.02%	4,565,966 $249 Million
Q3 2019 Nov 13, 2019	BUY	$58.58 - $83.91 $114 Million - $163 Million	1,946,782 Added 74.35%	4,565,244 $285 Million
Q2 2019 Aug 13, 2019	BUY	$63.59 - $78.71 $9.6 Million - $11.9 Million	150,931 Added 6.12%	2,618,462 $197 Million
Q1 2019 May 15, 2019	BUY	$50.75 - $80.54 $7.78 Million - $12.3 Million	153,276 Added 6.62%	2,467,531 $193 Million
Q4 2018 Feb 14, 2019	BUY	$52.18 - $67.93 $121 Million - $157 Million	2,314,255 New	2,314,255 $130 Million

Others Institutions Holding GKOS

# of Institutions

334

Shares Held

54.1M

Call Options Held

260K

Put Options Held

484K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.25B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brown Capital Management LLC with notifications on news.

Account

Brown Capital Management LLC Glaukos Corp Transaction History